Last reviewed · How we verify
NCT04672616: Ip
Inklusiv Plus: Mental Health Of Unemployed Adolescents And Young Adults
NA trial testing Group psychotherapy in Mental Disorder in 250 participants. Completed in 28 February 2023.
31 July 2022
Quick facts
| Lead sponsor | Zurich University of Applied Sciences |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 250 |
| Start date | 1 November 2020 |
| Primary completion | 31 July 2022 |
| Estimated completion | 28 February 2023 |
| Sites | 1 location across Switzerland |
Drugs / interventions tested
- Group psychotherapy
Conditions studied
- Mental Disorder — all drugs for Mental Disorder →
Sponsor
Zurich University of Applied Sciences
Who can join
16 and older, any sex, with Mental Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The expansion project "Inclusive Plus", which is financed by Innosuisse, is based on a pilot project. The psychotherapeutic offer developed in the previous project for psychologically burdened adolescents and young adults to support them in their professional integration was revised and supplemented and is being reviewed in this project. In addition to the group psychotherapeutic intervention, 5 one-on-one interviews are offered as needed. In addition, regular further training courses on mental health and illness in adolescence are implemented. And finally, a conference is to promote cooperation between referring physicians and bridge offers. The intervention will be implemented in 5 cantons (Zurich, Berne, Lucerne, St. Gallen, Appenzell Ausserrhoden) and in 7 different bridge services. The program is aimed at adolescents and young adults between 16 and 29 years of age who have sufficient knowledge of German. Participation is voluntary and the group size for the psychotherapy group is limited to 8 participants. The main question is whether the integration of young people with mental stress into the labor market is more successful. At three points in time (entry, exit, six months after exit) changes in selected indicators (including work ability, mental health, functional status, behaviour in seeking help) are measured. In addition, changes in the groups of participants will be surveyed. The implementation of the psychotherapy groups in the respective bridge offers will take place in autumn 2020, and the study will be completed with the last follow-up by the end of 2022.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04672616
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Group psychotherapy
Trials testing the same drug.
- NCT05314556 — Group Psychotherapy in Narcolepsy Type 1 · NA · completed
- NCT04490135 — Effectiveness of the Reitman Centre CARERS Group Intervention on Family Caregivers of Persons With Dementia · NA · completed
Other recruiting trials for Mental Disorder
Currently open trials in the same condition.
- NCT07010614 — Brain Stimulation to the Hippocampus in Schizophrenia · NA · recruiting
- NCT06929533 — Pharmacogenomics-Supported Psychotropic Prescribing Trial · NA · recruiting
- NCT06813066 — Simulating Psychotherapeutic Sessions With Generative Artificial Intelligence · NA · active not recruiting
- NCT06376734 — Search for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental Illness · Phase 2 · recruiting
- NCT06625437 — ACT for HIV-Positive Men · NA · recruiting
Other Zurich University of Applied Sciences trials
Trials by the same sponsor.
- NCT06037798 — The Cranio-cervical Flexion Test Using the NOD Device · completed
- NCT06003946 — Effectiveness of a Breathing and Relaxation Technique in Antenatal Education · NA · completed
- NCT05960760 — Attitudes Towards Back and Back Pain in German-speaking Switzerland · completed
- NCT04877561 — Test-Retest Reliability of the German Version of the Headache Disability Questionnaire (HDQ). · unknown
- NCT04816357 — Identification of Endometriosis and Migraine Criteria in Women With the Comorbidity of Both Conditions in Comparison Wit · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04672616 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Zurich University of Applied Sciences
- Last refreshed: 17 July 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04672616.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing